🔎 Trials Near Me

Home › Small Cell Lung Cancer › Missouri

Small Cell Lung Cancer clinical trials in Missouri

17 studies for Small Cell Lung Cancer are looking for participants at sites in Missouri.

Cities in Missouri

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

  • HCA MidAmerica Division, Inc., Kansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07472517

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

  • Missouri Cancer Associates, Columbia
  • Mercy South, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07218146

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • Washington University School of Medicine, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06712355

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

  • WA Uni School Of Med, St Louis
RecruitingPhase 1/2
Ages 18 to 100 · All sexes · Updated Aug 27, 2026 · NCT06726148

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

  • Washington University Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT07488923

Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)

  • Washington University School of Medicine, St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07155200

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

  • Mercy Clinic Oncology and Hematology Sindelar Cancer Center, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT06203210

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

  • Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07545954

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

  • MidAmerica Cancer Care, Kansas City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT06131840

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

  • Washington University School of Medicine (Siteman Cancer Center), St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT05652686

A Study of LY4175408 in Participants With Advanced Cancer

  • Washington University, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT07046923

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

  • University of Kansas Cancer Center - Briarcliff, Kansas City
  • University of Kansas Cancer Center - North, Kansas City
  • University of Kansas Cancer Center - Lee's Summit, Lee's Summit
  • and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT06769126

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

  • Washington University, St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT07030257

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

  • Washington University, St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jan 9, 2026 · NCT05490472

7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)

  • University of Missouri, Columbia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 2, 2025 · NCT07175077

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.